Distinct malignant behaviors of mouse myogenic tumors induced by different oncogenetic lesions

Area of Science:

• Oncology
• Cancer Biology
• Genetics

Background:

• Rhabdomyosarcomas (RMS) are heterogeneous cancers originating from myogenic cells.
• RMS exhibit diverse cytogenetic and mutational aberrations.
• Understanding genetic drivers of RMS malignancy is crucial for therapeutic development.

Purpose of the Study:

• To compare the malignant behavior of two genetically distinct mouse myogenic tumor models.
• To investigate the metastatic potential and tumor-repopulating capacity of different RMS subtypes.
• To elucidate how genetic alterations influence RMS progression and aggressiveness.

Main Methods:

• Initiation of Kras; p1619(null) myogenic tumors via oncogenic Kras expression in p16p19(null) mouse satellite cells.
• Initiation of SmoM2 tumors through ubiquitous expression of a mutant Smoothened allele.
• Assessment of metastatic spread to the lungs in tumor-bearing animals.
• Evaluation of tumor-repopulating ability in secondary recipients.

Main Results:

• Kras; p1619(null) tumors demonstrated significant lung metastasis in most animals.
• Kras; p1619(null) tumors successfully repopulated tumors in a high proportion of secondary recipients (7/9).
• SmoM2 tumors exhibited limited metastasis and lower tumor-repopulating capacity (2/18 recipients).

Conclusions:

• Genetically distinct myogenic tumors display markedly different malignant behaviors.
• The Kras; p1619(null) model exhibits a more aggressive, metastatic phenotype compared to the SmoM2 model.
• Genetic background plays a critical role in determining the metastatic potential and overall malignancy of rhabdomyosarcomas.